Information for Cagrilintide

Cagrilintide is a long-acting amylin analogue, developed as a successor to earlier versions like pramlintide. This compound is designed with an extended half-life and aims to address protein aggregation challenges observed in previous amylin analogues. Amylin, the natural counterpart, is a peptide produced by pancreatic beta cells and interacts with various body systems. Researchers are currently exploring Cagrilintide's potential, particularly in combination with other compounds like semaglutide, for its effects on appetite regulation and weight management.

Cagrilintide 5mg

GMP Certificates of Analysis

Cagrilintide
10mg
Batch #PKCAGR10924
09/11/2024

Product Usage

This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.